Sumesh Kaushal

Array ( [id] => 1335523 [patent_doc_number] => 06593133 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Neurotrophic factors' [patent_app_type] => B1 [patent_app_number] => 09/347613 [patent_app_country] => US [patent_app_date] => 1999-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 31096 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593133.pdf [firstpage_image] =>[orig_patent_app_number] => 09347613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6898323 [patent_doc_number] => 20010046488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-29 [patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERY OF AN ORGANIZED TISSUE TO AN ORGANISM' [patent_app_type] => new [patent_app_number] => 09/342305 [patent_app_country] => US [patent_app_date] => 1999-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9485 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20010046488.pdf [firstpage_image] =>[orig_patent_app_number] => 09342305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534375 [patent_doc_number] => 06489139 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'FabZ from Staphylococcus aureus' [patent_app_type] => B1 [patent_app_number] => 09/339614 [patent_app_country] => US [patent_app_date] => 1999-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16119 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489139.pdf [firstpage_image] =>[orig_patent_app_number] => 09339614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602513 [patent_doc_number] => 06432692 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Sensitive bioassay for detecting agonists of the aryl hydrocarbon receptor' [patent_app_type] => B1 [patent_app_number] => 09/337307 [patent_app_country] => US [patent_app_date] => 1999-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 10817 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432692.pdf [firstpage_image] =>[orig_patent_app_number] => 09337307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446397 [patent_doc_number] => 06368824 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Neuropeptide Y receptor Y5 and nucleic acid sequences' [patent_app_type] => B1 [patent_app_number] => 09/327035 [patent_app_country] => US [patent_app_date] => 1999-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 15295 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368824.pdf [firstpage_image] =>[orig_patent_app_number] => 09327035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1335158 [patent_doc_number] => 06593104 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Macular degeneration diagnostics and therapeutics' [patent_app_type] => B1 [patent_app_number] => 09/322357 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 33630 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593104.pdf [firstpage_image] =>[orig_patent_app_number] => 09322357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1511351 [patent_doc_number] => 06471957 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Canine IL-4 immunoregulatory proteins and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/322409 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72340 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/471/06471957.pdf [firstpage_image] =>[orig_patent_app_number] => 09322409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7613102 [patent_doc_number] => 06902731 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-07 [patent_title] => 'Methods of treating hyperproliferative disorders using retinoblastoma fusion proteins' [patent_app_type] => utility [patent_app_number] => 09/315116 [patent_app_country] => US [patent_app_date] => 1999-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 26 [patent_no_of_words] => 9897 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/902/06902731.pdf [firstpage_image] =>[orig_patent_app_number] => 09315116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477798 [patent_doc_number] => 06451593 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Design principle for construction of expression constructs for gene therapy' [patent_app_type] => B1 [patent_app_number] => 09/310842 [patent_app_country] => US [patent_app_date] => 1999-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12674 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451593.pdf [firstpage_image] =>[orig_patent_app_number] => 09310842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043409 [patent_doc_number] => 06866842 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-15 [patent_title] => 'Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction' [patent_app_type] => utility [patent_app_number] => 09/302896 [patent_app_country] => US [patent_app_date] => 1999-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 49 [patent_no_of_words] => 33378 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/866/06866842.pdf [firstpage_image] =>[orig_patent_app_number] => 09302896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1558463 [patent_doc_number] => 06436393 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Adenoviral vector encoding anti-apoptotic Bcl-2 gene and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/301836 [patent_app_country] => US [patent_app_date] => 1999-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 26 [patent_no_of_words] => 13122 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436393.pdf [firstpage_image] =>[orig_patent_app_number] => 09301836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6274649 [patent_doc_number] => 20020106354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'CELLULAR AND ANIMAL MODELS FOR DISEASES ASSOCIATED WITH ALTERED MITOCHONDRIAL FUNCTION' [patent_app_type] => new [patent_app_number] => 09/301517 [patent_app_country] => US [patent_app_date] => 1999-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13348 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106354.pdf [firstpage_image] =>[orig_patent_app_number] => 09301517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4255493 [patent_doc_number] => 06207876 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Adenosine deaminase deficient transgenic mice and methods for the use thereof' [patent_app_type] => 1 [patent_app_number] => 9/301665 [patent_app_country] => US [patent_app_date] => 1999-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 19 [patent_no_of_words] => 57489 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207876.pdf [firstpage_image] =>[orig_patent_app_number] => 301665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1452506 [patent_doc_number] => 06461606 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Materials and methods for gene therapy' [patent_app_type] => B1 [patent_app_number] => 09/299141 [patent_app_country] => US [patent_app_date] => 1999-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 61 [patent_no_of_words] => 16836 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/461/06461606.pdf [firstpage_image] =>[orig_patent_app_number] => 09299141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4323577 [patent_doc_number] => 06329170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Nucleic acids and proteins of a rat ganglioside GM1-specific .alpha.1.fwdarw.2fucosyltransferase and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/298886 [patent_app_country] => US [patent_app_date] => 1999-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 27257 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329170.pdf [firstpage_image] =>[orig_patent_app_number] => 298886 [rel_patent_id] =>[rel_patent_doc_number] =>)